1998
DOI: 10.1002/chin.199844284
|View full text |Cite
|
Sign up to set email alerts
|

ChemInform Abstract: The Cytotoxic Action of 1,3,5‐Triazabicyclo[3.1.0]hexane‐2,4‐diones and 1,3,5‐Triazine‐4,6‐(1H,5H)‐diones in Murine and Human Tumor Cells.

Abstract: 1998 pharmacology, medicinal chemistry, vaccines, serums pharmacology, medicinal chemistry, vaccines, serums V 1100 44 -284 The Cytotoxic Action of 1,3,5-Triazabicyclo[3.1.0]hexane-2,4-diones and 1,3,5-Triazine-4,6-(1H,5H)-diones in Murine and Human Tumor Cells. -A number of the tested title compounds like (I) and (II), prepared by literature methods, are found to be potent cytotoxic and antineoplastic agents, cf. derivatives (Ia)-(Ic). -(HALL, I. H.; TAYLOR, K.; IZYDORE, R. A.; COLEMAN, D. E.; MITCHELL, J. A.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Despite the fact that many of investigational and approved medicinal agents are 1,3,5‐triazine derivatives, there are little published reports on stability of those agents, particularly in the solid state 3–8. Moreover, there are no reports in the pharmaceutical literature regarding degradation profile of any pyrazolo‐[1,5‐a]‐1,3,5‐triazine derivatives.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the fact that many of investigational and approved medicinal agents are 1,3,5‐triazine derivatives, there are little published reports on stability of those agents, particularly in the solid state 3–8. Moreover, there are no reports in the pharmaceutical literature regarding degradation profile of any pyrazolo‐[1,5‐a]‐1,3,5‐triazine derivatives.…”
Section: Introductionmentioning
confidence: 99%